$HUM

UnitedHealthcare and Humana Drop Medicare Advantage Plans for Almost 1 Million Seniors

UnitedHealthcare and Humana are discontinuing Medicare Advantage plans affecting nearly 1 million Americans in 2027, citing higher medical expenses and profitability pressures. UnitedHealthcare will impact 390,000 members, focusing on PPO plans, while Humana will affect 600,000 members, targeting lower-performing plans. Both companies are also scaling back certain benefits for 2027, with UnitedHealthcare reducing dental benefits and Humana adjusting premium givebacks.

Original reporting
Published Oct 21, 2026, 10:29 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 11:23 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
UnitedHealthcare and Humana Drop Medicare Advantage Plans for Almost 1 Million Seniors — source image
Decision brief

The 30-second read

$HUMBearishMed
01

Why it matters

Both companies are reducing plan offerings to manage rising medical expenses, which may affect enrollment numbers and profit margins.

02

Market read

The announcement signals cost pressures in the Medicare Advantage space and could trigger short‑term stock moves for the two insurers.

03

What to watch

Potential cost savings from reduced dental and Part B givebacks may offset enrollment losses.

Relevance 7/10Novelty 7/10Timing: ahead of the Dec. 7 enrollment deadline

Background

UnitedHealthcare (UnitedHealth Group) and Humana are the two largest Medicare Advantage providers in the U.S., jointly covering millions of seniors.

Company-level read

Ticker impact

$HUMBearishHigh confidence
Context

Humana is dropping Medicare Advantage plans covering roughly 600,000 members, a fresh announcement that could impact its share price.

Expected impact

possible share weakness as the market assesses the impact on enrollment and profitability

Evidence & confidence

Eliminating a sizable portion of its Medicare Advantage enrollment signals cost challenges and may lower growth expectations.

Market effects

The Medicare Advantage market may see tighter enrollment and pricing pressure, affecting other insurers.

U.S. health insurance sector could experience short‑term volatility.

Limited to U.S. health‑care equities; no direct global impact.

Counterpoint

The plan cuts could improve profitability by shedding low‑margin products, offering a buying opportunity.

Key entities

  • UnitedHealth Group

    Parent of UnitedHealthcare, ticker UNH

  • Humana

    Ticker HUM

Related articles

$HUMMed

Humana’s $2.8 bn BlackRock deal follows Medicare Advantage ratings recovery

Humana (HUM) agreed to a $2.8 bn deal with BlackRock, restructuring ownership of 150 CenterWell clinics. BlackRock acquires WCAS's majority stake, with Humana retaining minority ownership. The deal reduces Humana's balance sheet obligations. Humana's Medicare Advantage star ratings improved, potentially increasing 2028 bonus payments to $4.8 bn, per Evercore ISI. S&P affirmed Humana's BBB rating but maintained a negative outlook.

$HUMMedAI 9/10

Seniors at About 150 CenterWell Clinics Face New Majority Owner as BlackRock Replaces Private Equity Backer

Humana announced that BlackRock's HPS Investment Partners will acquire Welsh Carson's stake in about 150 CenterWell clinics, valued at $2.8B. The deal, expected to close in Q4 2026, will make BlackRock the majority owner, with CenterWell retaining a minority stake and operational control. Humana stated patient care will remain unchanged, and the deal is not expected to materially affect its 2026 earnings guidance.

$HUMMedAI 8/10

Humana, BlackRock Strike $2.8 Bn Deal for CenterWell Clinics

Humana and BlackRock's HPS Investment Partners will form a joint venture to operate and expand CenterWell clinics, with BlackRock acquiring WCAS's stake for $2.8B. The deal aims to provide growth capital and lower costs for Humana, with no disruption to patient care. Humana may repurchase clinics starting 2028. The transaction is expected to close in Q4 2026, with no impact on 2026 earnings guidance.

$HUMMed

What Humana’s BlackRock Deal, Village Medical’s Divestitures Signal For Older Adult Primary Care

Humana (NYSE: HUM) announced a joint venture with BlackRock to manage 150 CenterWell clinics, while Village Medical divested 27 clinics to Harbor Health. These moves suggest a shift in the senior-focused primary care industry, with changes in ownership and financing strategies. Humana's deal includes a $2.8 billion equity acquisition and potential clinic purchases by CenterWell starting in 2028.

$HUMMedAI 8/10

Humana's CenterWell Expansion Gets a Boost From BlackRock's Capital

Humana (HUM) is forming a joint venture with BlackRock to own 150 CenterWell clinics, valued at $2.8B. BlackRock will hold majority ownership, with Humana retaining minority. The deal, expected to close in Q4 2026, will reduce Humana's liabilities and support clinic expansion. Humana's 2026 earnings guidance remains at least $9 per share.

$ANGOMed

AngioDynamics Announces Humana Medicare Advantage Coverage Policy Supporting Broader Access to NanoKnife IRE for Prostate and Liver Cancer

AngioDynamics announced that Humana updated its Medicare Advantage coverage policy to include NanoKnife IRE for prostate and liver cancer, effective October 1, 2026. This follows recent reimbursement milestones, including new CPT codes and Palmetto GBA's LCD L40205. Humana, with 7 million members, will use LCD L40205 criteria for coverage, subject to prior authorization.